BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17685017)

  • 1. [Kainic acid and neurobiology].
    Riljak V; Jandová K; Langmeier M
    Cesk Fysiol; 2006; 55(3):115-22. PubMed ID: 17685017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration.
    Eriksson C; Tehranian R; Iverfeldt K; Winblad B; Schultzberg M
    J Neurosci Res; 2000 Apr; 60(2):266-79. PubMed ID: 10740232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in mIPSCs and sIPSCs after kainate treatment: status epilepticus-induced neuronal loss or direct activation of kainate receptors?
    Shao LR; Dudek FE
    J Neurophysiol; 2006 Aug; 96(2):961-2. PubMed ID: 16672302
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in mIPSCs and sIPSCs after kainate treatment: possible actions mediated by the direct activation of kainate receptors.
    Rodríguez-Moreno A
    J Neurophysiol; 2006 Jul; 96(1):505. PubMed ID: 16611845
    [No Abstract]   [Full Text] [Related]  

  • 5. Kainic acid: insights into excitatory mechanisms causing selective neuronal degeneration.
    Coyle JT
    Ciba Found Symp; 1987; 126():186-203. PubMed ID: 3034525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal profile of clinical signs and histopathologic changes in an F-344 rat model of kainic acid-induced mesial temporal lobe epilepsy.
    Sharma AK; Jordan WH; Reams RY; Hall DG; Snyder PW
    Toxicol Pathol; 2008 Dec; 36(7):932-43. PubMed ID: 19126789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.
    Coyle JT; Ferkany JW; Zaczek R
    Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system.
    Oprica M; Eriksson C; Schultzberg M
    J Cell Mol Med; 2003; 7(2):127-40. PubMed ID: 12927051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kainate receptors in epilepsy and excitotoxicity.
    Vincent P; Mulle C
    Neuroscience; 2009 Jan; 158(1):309-23. PubMed ID: 18400404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission.
    Clarke VR; Ballyk BA; Hoo KH; Mandelzys A; Pellizzari A; Bath CP; Thomas J; Sharpe EF; Davies CH; Ornstein PL; Schoepp DD; Kamboj RK; Collingridge GL; Lodge D; Bleakman D
    Nature; 1997 Oct; 389(6651):599-603. PubMed ID: 9335499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of AMPA and kainate glutamate receptors impairs the viability of oligodendrocytes in vitro.
    Sanchez-Gomez MV; Matute C
    Int J Dev Biol; 1996; Suppl 1():187S-188S. PubMed ID: 9087754
    [No Abstract]   [Full Text] [Related]  

  • 12. GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells.
    Cossart R; Esclapez M; Hirsch JC; Bernard C; Ben-Ari Y
    Nat Neurosci; 1998 Oct; 1(6):470-8. PubMed ID: 10196544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate.
    Gröticke I; Hoffmann K; Löscher W
    Exp Neurol; 2008 Sep; 213(1):71-83. PubMed ID: 18585709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kainic Acid-Based Agonists of Glutamate Receptors: SAR Analysis and Guidelines for Analog Design.
    Tian Z; Clark BLM; Menard F
    ACS Chem Neurosci; 2019 Oct; 10(10):4190-4198. PubMed ID: 31550120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kainic acid triggers oligodendrocyte precursor cell proliferation and neuronal differentiation from striatal neural stem cells.
    Redondo C; López-Toledano MA; Lobo MV; Gonzalo-Gobernado R; Reimers D; Herranz AS; Paíno CL; Bazán E
    J Neurosci Res; 2007 May; 85(6):1170-82. PubMed ID: 17342781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kainate receptor agonists and antagonists mediate tolerance to kainic acid and reduce high-affinity GTPase activity in young, but not aged, rat hippocampus.
    Hesp BR; Wrightson T; Mullaney I; Kerr DS
    J Neurochem; 2004 Jul; 90(1):70-9. PubMed ID: 15198668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kainic acid-induced neurodegeneration and activation of inflammatory processes in organotypic hippocampal slice cultures: treatment with cyclooxygenase-2 inhibitor does not prevent neuronal death.
    Järvelä JT; Ruohonen S; Kukko-Lukjanov TK; Plysjuk A; Lopez-Picon FR; Holopainen IE
    Neuropharmacology; 2011 Jun; 60(7-8):1116-25. PubMed ID: 20932983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of ethanol on kainate receptors in cultured hippocampal neurons.
    Costa ET; Soto EE; Cardoso RA; Olivera DS; Valenzuela CF
    Alcohol Clin Exp Res; 2000 Feb; 24(2):220-5. PubMed ID: 10698375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kainate-evoked modulation of gene expression in rat brain.
    Kaminska B; Filipkowski RK; Biedermann IW; Konopka D; Nowicka D; Hetman M; Dabrowski M; Gorecki DC; Lukasiuk K; Szklarczyk AW; Kaczmarek L
    Acta Biochim Pol; 1997; 44(4):781-9. PubMed ID: 9584860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-fos regulates neuronal excitability and survival.
    Zhang J; Zhang D; McQuade JS; Behbehani M; Tsien JZ; Xu M
    Nat Genet; 2002 Apr; 30(4):416-20. PubMed ID: 11925568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.